Venous thromboembolism in metastatic pancreatic cancer.

Lauren Laderman,Krishnalatha Sreekrishnanilayam,Ramesh K Pandey,Elizabeth Handorf,Aryeh Blumenreich,Kristen A Sorice,Shannon M Lynch,Khadija Cheema,Lavanya Nagappan,Iberia R Sosa,Efrat Dotan,Namrata Vijayvergia

European journal of haematology（2023）

引用 0|浏览18

暂无评分

摘要

The results suggest mPC carries a significant VTE burden. VTE predicts poor outcomes from the point of median VTE occurrence. Advanced stage disease is the strongest risk factor. Future studies are needed to define risk stratification, survival benefit, and choice of thromboprophylaxis.

查看译文

关键词

anticoagulant,metastatic pancreatic cancer,thromboprophylaxis,venous thromboembolism

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要